Deep neck space infection (retropharyngeal / parapharyngeal / Ludwig — airway + sepsis triage, CT space-mapping, IV broad-spectrum ± surgical source control)
Encounter flow
12/12 authoredCanonical 12-phase frame with authored status for this dossier.
Frame
Frame as deep fascial-neck-space infection (retropharyngeal / parapharyngeal / prevertebral / submandibular-Ludwig / masticator / parotid / carotid-sheath) by source (odontogenic, tonsillar/pharyngeal, salivary, foreign-body, IVDU). The dominant tasks are AIRWAY-FIRST recognition, CT space-mapping, broad-spectrum IV cover, and surgical source control. The controlled-airway algorithm, the localised PTA drainage ladder, the upstream pharyngitis pathway, and the sepsis bundle are routed OUT by engine_id, not re-authored here.
deep-space scope + suspected source framed; airway/PTA/pharyngitis/sepsis ownership flagged for routing by engine_id
Patient inputs (16)
Brawny floor-of-mouth elevation with tongue protrusion/posterior displacement is the cardinal Ludwig sign and the single strongest difficult-airway predictor in submandibular-space disease (Dowdy Anesth Prog 2019 PMID 31184944)
Trismus localises masticator/parapharyngeal/submandibular involvement, predicts difficult oral access for both exam and airway, and discriminates deep-space spread from uncomplicated pharyngitis (Sheikh Clin Otolaryngol 2023 PMID 37147934)
Neck stiffness / torticollis / odynophagia out of proportion / refusal of neck extension localises retropharyngeal-prevertebral spread and is a descending-mediastinitis precursor (Hu Medicina 2022 PMID 36556959 — retropharyngeal/anterior-visceral spread predicts DNM)
Fever supports a suppurative process and severity class; high fever + rigors raises the bacteraemia/Lemierre concern (Charlton J Laryngol Otol 2024 PMID 39434660)
Diabetes is an independent predictor of complications, multispace involvement, and prolonged hospitalisation in deep-neck infection — lowers admission/CT/surgical threshold (Bandol Medicina 2025 PMID 39859111 — DM strongly associated with complications p<0.001; Wu Sci Prog 2021 PMID 34191640 — rising DM rate)
Stridor, "can't lie flat", tripod posture, drooling/pooled secretions, or rapidly progressive distress is the do-NOT-delay airway-emergency trigger; floor-of-mouth elevation predicts a difficult airway (Bridwell/Long Am J Emerg Med 2020 PMID 33383265; Dowdy Anesth Prog 2019 PMID 31184944)
Pleuritic chest/back pain, dyspnoea, or widened mediastinum suggests descending necrotising mediastinitis — recognise then route to cardiothoracic (Hu Medicina 2022 PMID 36556959 — untreated mortality up to 85%)
Rigors, anterior-neck-vein tenderness/cord, pleuritic chest pain, and septic pulmonary emboli after an oropharyngeal infection suggest Fusobacterium internal-jugular septic thrombophlebitis (Lemierre's) (Tiwari Cureus 2023 PMID 37724228; Wright South Med J 2012 PMID 22561543)
Hypotension on adequate fluids with a deep-neck source → systemic toxicity / septic shock; recognise then route OUT to id.sepsis.core.v1 (SSC — sepsis pathway not authored here)
Contrast CT neck (extended to chest if any mediastinal feature) is the space/abscess-mapping and descending-mediastinitis instrument; POCUS is an adjunct when the patient cannot lie flat (Sheikh Clin Otolaryngol 2023 PMID 37147934 — CT in 78%; Bridwell/Long Am J Emerg Med 2020 PMID 33383265)
Immunosuppression / transplant broadens the pathogen spectrum (incl. atypical/fungal), blunts containment, and is strongly associated with complications — lower imaging/source-control threshold (Bandol Medicina 2025 PMID 39859111)
IV drug use (jugular-route seeding, unusual organisms incl. S. aureus/MRSA) and recent instrumentation/foreign body change the source, organism, and carotid-sheath-erosion risk (Sheikh Clin Otolaryngol 2023 PMID 37147934)
Markedly elevated/rising CRP predicts surgical drainage need, mediastinal extension, and prolonged hospitalisation (Arslan J Investig Med 2022 PMID 35760449 — CRP >133 mg/L; Hu Medicina 2022 PMID 36556959 — CRP 340.9 vs 190.1 mediastinal vs not)
Neutrophilic leukocytosis supports a suppurative process and feeds the severity / mediastinitis-risk chain (Wu Sci Prog 2021 PMID 34191640 — higher leucocyte counts over time)
Anticoagulation / bleeding diathesis changes the drainage risk-benefit and is central to the unresolved Lemierre internal-jugular-thrombosis anticoagulation debate (Adedeji Ann Pharmacother 2020 PMID 32909436)
Antibiotic-safety gating for the empiric regimen (β-lactam/β-lactamase-inhibitor + clindamycin generally preferred; weigh metronidazole) and a difficult-airway modifier in late pregnancy (Aliabadi Eur J Transl Myol 2022 PMID 36268928 — odontogenic antibiotics in pregnancy)
* = hard-required. Engine cannot meaningfully run until these are filled.
Severity triggers (8)
- informationallife_threateningairway_obstruction_secure_and_route_controlled_airwayStridor, "can't lie flat", drooling/pooled secretions, floor-of-mouth elevation with tongue displacement, or rapidly progressive distress — impending deep-neck/Ludwig airway obstruction (Bridwell/Long Am J Emerg Med 2020 PMID 33383265; Dowdy Anesth Prog 2019 PMID 31184944)Trigger could not be auto-evaluated — needs clinician judgement.
- informationallife_threateningdescending_necrotizing_mediastinitisPleuritic chest/back pain, dyspnoea, widened mediastinum, retropharyngeal/anterior-visceral spread, or very high/rapidly rising CRP (e.g. ~340 vs ~190 mg/L mediastinal vs non-mediastinal) (Hu Medicina 2022 PMID 36556959 — untreated mortality up to 85%)Trigger could not be auto-evaluated — needs clinician judgement.
- informationallife_threateninglemierre_internal_jugular_septic_thrombophlebitisRigors, anterior-neck-vein tenderness/cord, pleuritic chest pain, and septic pulmonary emboli after an oropharyngeal infection — Fusobacterium necrophorum internal-jugular septic thrombophlebitis (Tiwari Cureus 2023 PMID 37724228; Wright South Med J 2012 PMID 22561543)Trigger could not be auto-evaluated — needs clinician judgement.
- informationallife_threateningcervical_necrotizing_fasciitis_route_outRapidly spreading neck erythema/induration with crepitus, dishwater discharge, pain out of proportion, or cutaneous anaesthesia — cervical necrotising fasciitis (Sheikh Clin Otolaryngol 2023 PMID 37147934 — a recognised DNSI complication theme)Trigger could not be auto-evaluated — needs clinician judgement.
- informationallife_threateningcarotid_sheath_erosion_sentinel_bleedCarotid-space involvement on CT with a sentinel/herald bleed (oral/aural/wound), expanding pulsatile neck mass, or cranial-nerve palsy — impending carotid blow-out (Sheikh Clin Otolaryngol 2023 PMID 37147934 — carotid-sheath involvement theme)Trigger could not be auto-evaluated — needs clinician judgement.
- informationalseveresystemic_toxicity_route_to_sepsisqSOFA ≥2, hypotension on adequate fluids, or NEWS2/SIRS-positive systemic toxicity with the deep-neck source (SSC)Trigger could not be auto-evaluated — needs clinician judgement.
- informationalseveremultispace_or_retropharyngeal_prevertebral_spread≥2 deep neck spaces, or retropharyngeal/prevertebral/anterior-visceral involvement on CT, ± gas formation — the mediastinitis precursor and surgical-drainage indication (Arslan J Investig Med 2022 PMID 35760449 — ≥2 spaces / gas indicate surgical drainage; Hu Medicina 2022 PMID 36556959)Trigger could not be auto-evaluated — needs clinician judgement.
- informationalmoderateimmunocompromised_or_diabetic_high_riskDiabetes, immunosuppression, or transplant with deep-neck infection — broader pathogen spectrum, more multispace involvement, higher complication and prolonged-hospitalisation rates, lower CT/surgical/ICU threshold (Bandol Medicina 2025 PMID 39859111 — DM/immunocompromise associated with complications p<0.001; Wu Sci Prog 2021 PMID 34191640 — rising DM rate)Trigger could not be auto-evaluated — needs clinician judgement.
Workflow calculators
Run this disease's risk and dosing calculators inline.
Recommended regimen
Deep neck space infection — airway-secure → surgical source control → IV broad-spectrum (anaerobe + strep + MRSA) + Lemierre anticoagulation branch- controlled_definitive_airway_flexible_awake_with_surgical_backupfirst lineairway_managementtriggers: stridor, cannot_lie_flat, floor_of_mouth_elevation, drooling, progressive_distressBridwell/Long Am J Emerg Med 2020 (PMID 33383265) — first-line airway approach is flexible intubating endoscopy with preparation for a surgical airway; Dowdy Anesth Prog 2019 (PMID 31184944) — Ludwig is a predicted difficult airway: do NOT force supine / blind oral intubation; mark external airway landmarks. The controlled-airway algorithm itself is routed to ent.epiglottitis.core.v1.
ed playbook — drug actions (4)
- 1. controlled definitive airway (flexible/awake, surgical-airway backup)procedure • airway • once; continuous vigilancetrigger: Threatened airway / Ludwig / retropharyngeal disease (Bridwell/Long Am J Emerg Med 2020 PMID 33383265)Airway-first; Ludwig is a predicted difficult airway — do not force supine / blind oral intubation
- 2. ampicillin-sulbactam IV (empiric backbone)rxcui 10091483 g • IV • q6htrigger: All deep-neck infection — strep + anaerobe cover (Sheikh Clin Otolaryngol 2023 PMID 37147934)Streptococcal + oral-anaerobe (incl. Fusobacterium) backbone
- 3. vancomycin IV (add MRSA cover if IVDU / healthcare exposure / severe)rxcui 1112415-20 mg/kg • IV • q8-12h AUC-guidedtrigger: IVDU / healthcare exposure / prior MRSA / severe diseaseEmpiric MRSA cover for the IVDU/severe phenotype
- 4. clindamycin IV (penicillin anaphylaxis backbone)rxcui 2582600-900 mg • IV • q8htrigger: Severe penicillin allergyStrep + anaerobe backbone substitute; add MRSA/Gram-negative per source; C. difficile counsel
Auto-drafted A&P note
edSubjective
- Possible entry pathways: Neck swelling / induration with pain, fever, dysphagia, odynophagia and trismus over 1-5 days — the cardinal deep-neck-space-infection presentation (Sheikh Clin Otolaryngol 2023 PMID 37147934; Charlton J Laryngol Otol 2024 PMID 39434660); Bilateral submandibular brawny induration with floor-of-mouth elevation, tongue protrusion/displacement and drooling — Ludwig's angina, a do-not-delay airway emergency (Bridwell/Long Am J Emerg Med 2020 PMID 33383265; Dowdy Anesth Prog 2019 PMID 31184944); Upstream ENT engine flagged deep-space / airway red flags and routed IN by engine_id (reciprocal entry from ent.pharyngitis.core.v1 / ent.peritonsillar-abscess.core.v1 / ent.epiglottitis.core.v1) (Sheikh Clin Otolaryngol 2023 PMID 37147934).
Objective
- No vitals, labs, or imaging entered for this encounter.
Assessment
**Deep neck space infection (retropharyngeal / parapharyngeal / Ludwig — airway + sepsis triage, CT space-mapping, IV broad-spectrum ± surgical source control)** (ent.deep-neck-space-infection.core.v1). Phenotype framing: Terminal differential with pivot findings: deep-neck-space abscess vs peritonsillar abscess (peritonsillar-localised bulge + uvular deviation, neck supple — route to ent.peritonsillar-abscess.core.v1) vs epiglottitis (supraglottic, near-normal oropharynx, "thumbprint" — route to ent.epiglottitis.core.v1) vs uncomplicated pharyngitis/tonsillitis (symmetric, no trismus / floor-of-mouth elevation / neck stiffness — route to ent.pharyngitis.core.v1) vs cervical lymphadenitis (discrete mobile tender node, no fascial-space tracking on CT) vs infected branchial/thyroglossal congenital cyst (longstanding cystic lesion in a typical location, recurrent, less toxic) vs cervical necrotising fasciitis (crepitus, dishwater discharge, pain out of proportion) vs Lemierre (IJ thrombus + septic emboli pivot). Scope: Frame as deep fascial-neck-space infection (retropharyngeal / parapharyngeal / prevertebral / submandibular-Ludwig / masticator / parotid / carotid-sheath) by source (odontogenic, tonsillar/pharyngeal, salivary, foreign-body, IVDU). The dominant tasks are AIRWAY-FIRST recognition, CT space-mapping, broad-spectrum IV cover, and surgical source control. The controlled-airway algorithm, the localised PTA drainage ladder, the upstream pharyngitis pathway, and the sepsis bundle are routed OUT by engine_id, not re-authored here. No severity triggers fired against current inputs.
Plan
Regimen axis: **Deep neck space infection — airway-secure → surgical source control → IV broad-spectrum (anaerobe + strep + MRSA) + Lemierre anticoagulation branch** — step "Step 1 — Airway-first: secure the airway before anything else if threatened". 1. controlled_definitive_airway_flexible_awake_with_surgical_backup (airway_management, first line) — Bridwell/Long Am J Emerg Med 2020 (PMID 33383265) — first-line airway approach is flexible intubating endoscopy with preparation for a surgical airway; Dowdy Anesth Prog 2019 (PMID 31184944) — Ludwig is a predicted difficult airway: do NOT force supine / blind oral intubation; mark external airway landmarks. The controlled-airway algorithm itself is routed to ent.epiglottitis.core.v1. Setting playbook (ed) — Recognise + secure a threatened airway, screen + route the catastrophic complications, CT-map the space(s), start IV broad-spectrum cover, and mobilise urgent ENT/OMFS surgical source control (Bridwell/Long Am J Emerg Med 2020 PMID 33383265; Sheikh Clin Otolaryngol 2023 PMID 37147934) 2. controlled definitive airway (flexible/awake, surgical-airway backup) procedure airway once; continuous vigilance — Threatened airway / Ludwig / retropharyngeal disease (Bridwell/Long Am J Emerg Med 2020 PMID 33383265) (Airway-first; Ludwig is a predicted difficult airway — do not force supine / blind oral intubation) 3. ampicillin-sulbactam IV (empiric backbone) 3 g IV q6h — All deep-neck infection — strep + anaerobe cover (Sheikh Clin Otolaryngol 2023 PMID 37147934) (Streptococcal + oral-anaerobe (incl. Fusobacterium) backbone) 4. vancomycin IV (add MRSA cover if IVDU / healthcare exposure / severe) 15-20 mg/kg IV q8-12h AUC-guided — IVDU / healthcare exposure / prior MRSA / severe disease (Empiric MRSA cover for the IVDU/severe phenotype) 5. clindamycin IV (penicillin anaphylaxis backbone) 600-900 mg IV q8h — Severe penicillin allergy (Strep + anaerobe backbone substitute; add MRSA/Gram-negative per source; C. difficile counsel) Non-pharmacologic actions: - Urgent ENT/OMFS referral for surgical source control of a drainable collection (Sheikh Clin Otolaryngol 2023 PMID 37147934 — drainage ~81%) - Do NOT delay airway control or surgical source control for imaging/antibiotics (Bridwell/Long Am J Emerg Med 2020 PMID 33383265) - Send blood + intra-operative deep-space aspirate cultures incl. anaerobic/Fusobacterium media - IV fluids + analgesia for drooling/odynophagia-related dehydration AVOID / contraindication checks: - Penicillin anaphylaxis block ampicillinsulbactam piptazo ceftriaxone (use clindamycin ± metronidazole ± MRSA agent — backbone substitution) - Clindamycin c diff counsel (lincosamide C. difficile risk) - Metronidazole alcohol disulfiram reaction counsel - Vancomycin AUC guided dosing and renal monitoring (Inker NEJM 2021 race free eGFR for AUC dosing) - Linezolid serotonin syndrome and myelosuppression monitoring - Lemierre anticoagulation is debated decide case by case not routine (Adedeji Ann Pharmacother 2020 — efficacious/safe but controversial; 6 12 wk if used) - Pregnancy prefer betalactam or clindamycin weigh metronidazole (Aliabadi Eur J Transl Myol 2022 — odontogenic antibiotic safety in pregnancy) - Do not delay airway or surgical source control for antibiotics (Bridwell/Long Am J Emerg Med 2020 — airway + source control are primary)
Monitoring
Regimen monitoring: - improvement expected within 48-72h of source control plus antibiotics (Sheikh Clin Otolaryngol 2023 PMID 37147934) - rising CRP or new chest back pain reimage CT neck to chest for DNM (Hu Medicina 2022 PMID 36556959) - continuous airway vigilance reobstruction and tracheostomy decisions (Kim J Oral Maxillofac Surg 2021 PMID 34582808 — maintained orotracheal intubation favoured over upfront tracheotomy) - delayed Lemierre watch rigors septic pulmonary emboli neck vein tenderness (Tiwari Cureus 2023 PMID 37724228) - carotid sheath sentinel bleed watch in carotid space involvement - renal dose recheck for betalactam vancomycin metronidazole (Inker NEJM 2021) Setting (ed) monitoring: - Continuous airway re-check; return precautions for airway, mediastinitis, Lemierre - CRP/WBC baseline; very high/rising CRP → extend CT to chest (Hu Medicina 2022 PMID 36556959) Follow-up plan: Definitive source eradication (dental extraction/endodontics for an odontogenic source, tonsillectomy candidacy if recurrent tonsillar source, salivary-duct management); diabetes optimisation (DM is a recurrence + complication driver — Bandol Medicina 2025); IVDU harm-reduction / addiction referral; ENT/OMFS follow-up; counsel return precautions for re-accumulation, airway, mediastinitis, and Lemierre. Anticoagulation-duration follow-up if a Lemierre IJ thrombus was treated (Adedeji Ann Pharmacother 2020 — 6-12 wk). - Close-out criterion: definitive source-eradication plan + comorbidity optimisation + follow-up + return precautions documented Monitoring phase: Expect improvement within 48-72 h of adequate source control + antibiotics; persistent fever, rising CRP, new chest/back pain, or expanding neck → re-image (CT neck-to-chest) for inadequate drainage / new space / descending mediastinitis, do NOT silently extend antibiotics. Continuous airway vigilance (re-obstruction, tracheostomy decisions — Kim J Oral Maxillofac Surg 2021 favoured maintained orotracheal intubation over upfront tracheotomy). Watch for delayed Lemierre (septic pulmonary emboli) and carotid sentinel bleed.
Disposition
Current setting: ed — Recognise + secure a threatened airway, screen + route the catastrophic complications, CT-map the space(s), start IV broad-spectrum cover, and mobilise urgent ENT/OMFS surgical source control (Bridwell/Long Am J Emerg Med 2020 PMID 33383265; Sheikh Clin Otolaryngol 2023 PMID 37147934) Disposition criteria: - Admit ALL deep-neck-space infection; ICU for threatened/secured airway, mediastinitis, septic shock, multispace disease, or significant comorbidity (Charlton J Laryngol Otol 2024 PMID 39434660 — ICU ~32%) - Route OUT by engine_id if airway / mediastinitis / Lemierre / sepsis positive (carryover: CT space map, CRP, organism, airway status) Escalation triggers (move to higher acuity): - Airway obstruction → secure airway + route the controlled-airway doctrine to ent.epiglottitis.core.v1 (Dowdy Anesth Prog 2019 PMID 31184944) - Descending mediastinitis (chest/back pain, very high CRP, anterior-visceral/retropharyngeal spread) → cardiothoracic + ICU (Hu Medicina 2022 PMID 36556959) - qSOFA ≥2 / hypotension → id.sepsis.core.v1 (SSC) - Lemierre features → ensure anaerobic cover; ID + case-by-case anticoagulation discussion (Adedeji Ann Pharmacother 2020 PMID 32909436)
Earlier-Return Triggers
Return-precaution thresholds (watch for): - [LIFE_THREATENING] Stridor, "can't lie flat", drooling/pooled secretions, floor-of-mouth elevation with tongue displacement, or rapidly progressive distress — impending deep-neck/Ludwig airway obstruction (Bridwell/Long Am J Emerg Med 2020 PMID 33383265; Dowdy Anesth Prog 2019 PMID 31184944) - [LIFE_THREATENING] Pleuritic chest/back pain, dyspnoea, widened mediastinum, retropharyngeal/anterior-visceral spread, or very high/rapidly rising CRP (e.g. ~340 vs ~190 mg/L mediastinal vs non-mediastinal) (Hu Medicina 2022 PMID 36556959 — untreated mortality up to 85%) - [LIFE_THREATENING] Rigors, anterior-neck-vein tenderness/cord, pleuritic chest pain, and septic pulmonary emboli after an oropharyngeal infection — Fusobacterium necrophorum internal-jugular septic thrombophlebitis (Tiwari Cureus 2023 PMID 37724228; Wright South Med J 2012 PMID 22561543)
Citations
- No single society "deep neck space infection guideline" exists; operating authority set — Sheikh et al systematic review & qualitative evidence synthesis of DNSI assessment/management (Clin Otolaryngol 2023, 60 studies) + Charlton et al UK 53-case DNSI cohort (J Laryngol Otol 2024) + Asairinachan et al Australian 422-patient DNSI cohort (ANZ J Surg 2025) + Arslan et al DNI laboratory/imaging treatment-strategy study (J Investig Med 2022) + Hu et al risk factors for descending necrotising mediastinitis in deep neck abscess (Medicina 2022) + Kim et al optimal airway management in DNM (J Oral Maxillofac Surg 2021) + Ma et al multidisciplinary DNM treatment (J Int Med Res 2019) + Bridwell/Long Ludwig's angina evidence-based review (Am J Emerg Med 2020) + Dowdy et al Ludwig's angina anaesthetic/airway management (Anesth Prog 2019) + Tiwari Lemierre's 21st-century review (Cureus 2023) + Adedeji et al Lemierre anticoagulation systematic review (Ann Pharmacother 2020) + Wright et al Lemierre syndrome (South Med J 2012); all WebSearch/PubMed reconciled 2026-05-17 [PMID:37147934](https://pubmed.ncbi.nlm.nih.gov/37147934/) - Cited evidence (PMID 39434660) [PMID:39434660](https://pubmed.ncbi.nlm.nih.gov/39434660/) - Cited evidence (PMID 39812241) [PMID:39812241](https://pubmed.ncbi.nlm.nih.gov/39812241/) - Cited evidence (PMID 35760449) [PMID:35760449](https://pubmed.ncbi.nlm.nih.gov/35760449/) - Cited evidence (PMID 36556959) [PMID:36556959](https://pubmed.ncbi.nlm.nih.gov/36556959/) Last reconciled with current guidelines: 2026-05-17.
- No single society "deep neck space infection guideline" exists; operating authority set — Sheikh et al systematic review & qualitative evidence synthesis of DNSI assessment/management (Clin Otolaryngol 2023, 60 studies) + Charlton et al UK 53-case DNSI cohort (J Laryngol Otol 2024) + Asairinachan et al Australian 422-patient DNSI cohort (ANZ J Surg 2025) + Arslan et al DNI laboratory/imaging treatment-strategy study (J Investig Med 2022) + Hu et al risk factors for descending necrotising mediastinitis in deep neck abscess (Medicina 2022) + Kim et al optimal airway management in DNM (J Oral Maxillofac Surg 2021) + Ma et al multidisciplinary DNM treatment (J Int Med Res 2019) + Bridwell/Long Ludwig's angina evidence-based review (Am J Emerg Med 2020) + Dowdy et al Ludwig's angina anaesthetic/airway management (Anesth Prog 2019) + Tiwari Lemierre's 21st-century review (Cureus 2023) + Adedeji et al Lemierre anticoagulation systematic review (Ann Pharmacother 2020) + Wright et al Lemierre syndrome (South Med J 2012); all WebSearch/PubMed reconciled 2026-05-17 — PMID:37147934
- Cited evidence (PMID 39434660) — PMID:39434660
- Cited evidence (PMID 39812241) — PMID:39812241
- Cited evidence (PMID 35760449) — PMID:35760449
- Cited evidence (PMID 36556959) — PMID:36556959